VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PLUR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
PLURPluri Inc.
$0.94$8M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPLURFinancials

Pluri Inc. (PLUR) Income Statement

25Y historyFree accessUpdated daily

Revenue volatility remains a primary concern, highlighted by a 60.9% year-over-year decline in 2026Q3 and an operating margin that reached -39.2% during the same period.

Income StatementBalance SheetCash FlowRatios

PLUR Income Statement

Annual statement

PLUR Income Statement

Pluri Inc. (PLUR) annual income statement — 25-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMJun'26Jun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02
Sales/Revenue2.14M1.02M1.34M326K287K234K023K54K50K02.85M379K379K679K716K-1.68M000000000
Revenue Growth %61.39%-23.95%309.82%13.59%22.65%--100%-57.41%8%--100%651.19%0%-44.18%-5.17%142.57%----------
Cost of Goods Sold1.25M563K682K4K9K1.05M1.37M1.57M2K2K2.18M100K13K11K20K21K0000000006K
COGS % of Revenue-55.41%51.05%1.23%3.14%450%-6826.09%3.7%4%-3.51%3.43%2.9%2.95%2.93%----------
Gross Profit886K453K654K322K278K-819K-1.37M-1.55M52K48K-2.18M2.75M366K368K659K695K-1.68M00000000-6K
Gross Margin %41.4%44.59%48.95%98.77%96.86%-350%--6726.09%96.3%96%-96.49%96.57%97.1%97.05%97.07%100%---------
Gross Profit Growth %--30.73%103.11%15.83%133.94%40.22%11.44%-3075%8.33%102.2%-179.25%650.55%-0.54%-44.16%-5.18%141.32%--------100%-
Operating Expenses54.45M25.39M22.83M22.48M27.52M40.77M49.25M27.93M35.58M33.78M28.02M26.07M25.63M28.22M22.88M15.75M11.11M7.23M6.56M10.43M6.28M2.33M2.83M3M210.49K74.45K
OpEx % of Revenue-2499.11%1708.83%6895.71%9590.24%17424.79%-121430.43%65896.3%67558%-915.56%6763.32%7445.38%3369.96%2199.3%-660.76%---------
Selling, General & Admin17.89M10.3M9.98M10.03M11.78M17.45M20.56M7.8M9.16M11.19M6.93M6.49M6.46M8.68M5.65M6.57M4.49M3.14M3.42M6.04M3.73M1.03M873.65K1.78M112.96K74.45K
SG&A % of Revenue-1013.68%746.93%3077.91%4104.18%7457.26%-33934.78%16957.41%22386%-227.82%1704.49%2289.18%831.96%917.32%-266.65%---------
Research & Development36.56M15.09M12.85M12.45M15.74M24.38M30.07M20.12M24.59M22.63M21.09M19.58M19.17M19.54M17.23M9.18M6.63M4.3M3.14M4.39M2.55M1.3M1.79M1.22M79.87K0
R&D % of Revenue-1485.43%961.9%3817.79%5486.06%10417.52%-87495.65%45529.63%45258%-687.74%5058.84%5156.2%2538%1281.98%-394.11%---------
Other Operating Expenses00000-1.05M-1.37M000000000000000168.62K000
Operating Income-53.56M-24.94M-22.18M-22.16M-27.25M-41.59M-50.62M-29.48M-35.53M-33.73M-28.02M-23.32M-25.27M-27.85M-22.22M-15.03M-11.11M-7.44M-6.56M-10.43M-6.28M-2.33M-2.83M-3M-457K-74.45K
Operating Margin %-2502.94%-2454.53%-1659.88%-6796.93%-9493.38%-17774.79%--128156.52%-65800%-67462%--819.07%-6666.75%-7348.28%-3272.9%-2099.3%660.76%---------
Operating Income Growth %--12.45%-0.08%18.67%34.49%17.84%-71.74%17.04%-5.34%-20.39%-20.16%7.71%9.27%-25.32%-47.85%-35.24%-49.4%-13.43%37.12%-66.2%-169.08%17.6%5.82%-557.55%-513.81%-
EBITDA-52.7M-24.46M-21.86M-21.91M-26.88M-40.54M-49.25M-27.91M-33.57M-31.71M-25.84M-21.17M-23.19M-25.95M-21.19M-14.6M-10.8M-7.23M-6.38M-10.3M-6.22M-2.29M-2.8M-2.91M-435.96K-74.45K
EBITDA Margin %-2462.57%-2407.68%-1636.23%-6719.33%-9367.25%-17324.79%--121330.43%-62166.67%-63426%--743.55%-6119.53%-6846.44%-3120.77%-2038.55%642.21%---------
EBITDA Growth %-129.66%-11.9%0.21%18.52%33.69%17.69%-76.5%16.87%-5.86%-22.72%-22.07%8.73%10.62%-22.45%-45.18%-35.12%-49.36%-13.27%38.01%-65.63%-171.61%18.11%4.04%-568.28%-485.55%-
D&A (Non-Cash Add-back)388K0316K253K362K1.05M1.37M1.57M1.96M2.02M2.18M2.15M2.07M1.9M1.03M435K312K207K173K129K56.49K42.54K34.23K91.54K21.04K0
EBIT-52.67M-24.46M-22.38M-20.48M-28.04M-40.49M-49.79M-28.96M-35.31M-26.13M-27.75M-23.32M-25.27M-27.85M-21.13M-15.03M-10.84M-7.44M-6.68M-10.48M-7.48M-2.14M-1.91M-1.93M00
Net Interest Income-1.34M-932K271K448K241K-306K414K188K356K-661K049K75K210K510K563K223K-29K6K0000000
Interest Income282K01.14M1.31M1.08M581K492K384K385K276K122K149K112K246K539K575K236K014K0000000
Interest Expense1.63M932K873K866K843K887K78K196K29K937K0100K37K36K29K12K13K31K8K023.02K00003.45K
Other Income/Expense-263K-456K-1.08M814K-1.64M219K758K324K225K7.61M205K73K590K918K1.07M237K266K-14K-84K-69K-2.15M-107K731.64K994.17K00
Pretax Income-53.83M-25.39M-23.25M-21.34M-28.89M-41.37M-49.87M-29.15M-35.31M-26.13M-27.81M-23.25M-24.68M-26.93M-21.16M-14.79M-11.07M-7.46M-6.64M-10.5M-8.24M-2.44M-2.1M-2.01M418.26K0
Pretax Margin %-2515.23%-2499.41%-1740.64%-6547.24%-10065.16%-17681.2%--126747.83%-65383.33%-52252%--816.51%-6511.08%-7106.07%-3115.61%-2066.2%658.2%---------
Income Tax-21K-25K-5K00000-94K0-205K-73K0029K0-266K14K78K69K2.15M000252.5K77.9K
Effective Tax Rate %0.04%0.1%0.02%0%0%0%0%0%0.27%0%0.74%0.31%0%0%-0.14%0%2.4%-0.19%-1.17%-0.66%-26.15%0%0%0%60.37%-
Net Income-48.47M-23.82M-22.58M-20.89M-28.32M-41.24M-49.87M-29.15M-35.31M-26.13M-27.81M-23.25M-24.68M-26.93M-21.16M-14.79M-10.85M-7.45M-6.64M-10.5M-8.43M-2.44M-2.1M-2.01M-463K-77.9K
Net Margin %-2265.14%-2344.59%-1690.34%-6407.36%-9867.94%-17624.79%--126747.83%-65383.33%-52252%--816.51%-6511.08%-7106.07%-3115.61%-2066.2%644.95%---------
Net Income Growth %-114.95%-5.48%-8.11%26.25%31.33%17.29%-71.05%17.43%-35.14%6.07%-19.65%5.8%8.37%-27.31%-43%-36.38%-45.55%-12.31%36.79%-24.55%-245.45%-16.3%-4.38%-334.13%-494.33%-
Net Income (Continuing)-53.8M-25.37M-23.25M-21.34M-28.89M-41.37M-49.87M-29.15M-35.31M-26.13M-27.81M-23.25M-24.68M-26.93M-21.16M-14.79M-10.85M-7.45M-6.64M-10.5M-8.43M-2.44M-2.1M-2.01M-463K-77.9K
Discontinued Operations00000000000000000000000000
Minority Interest5.67M5.6M5.98M5.32M1.95M2.15M00000000000000000000
EPS (Diluted)-3.98-2.44-3.56-3.99-6.18-10.24-14.19-12.80-23.20-19.74-25.45-23.38-28.09-33.92-30.50-26.88-27.82-35.06-50.07-130.77-467.52-639.99-202.86-120.34-27.71-4.66
EPS Growth %-38.72%31.46%10.78%35.44%39.65%27.84%-10.86%44.83%-17.53%22.44%-8.85%16.77%17.19%-11.21%-13.47%3.38%20.65%29.98%61.71%72.03%26.95%-215.48%-68.57%-334.28%-494.64%-
EPS (Basic)--2.44-3.56-3.99-6.18-10.24-14.19-12.80-23.20-19.74-25.45-23.38-28.09-33.92-30.50-26.88-27.82-35.06-50.07-130.77-467.52-639.99-202.86-120.34-27.71-4.66
Diluted Shares Outstanding12.18M9.74M6.34M5.24M4.58M4.02M3.51M2.27M1.54M1.32M1.09M994.35K878.55K793.93K693.52K550.4K389.99K212.56K132.54K80.28K18.03K3.81K10.34K16.71K16.71K16.71K
Basic Shares Outstanding12.18M9.74M6.34M5.24M4.58M4.02M3.51M2.27M1.54M1.32M1.09M994.35K878.55K793.93K693.52K550.4K389.99K212.56K132.54K80.28K18.03K3.81K10.34K16.71K16.71K16.71K
Dividend Payout Ratio--------------------------

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Insufficient liquidity for operations

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Revenue Volatility Masks Strategic Pivot

As indicated by the most recent quarterly data, Pluri's revenue remains highly erratic, with a 60.9% year-over-year decline in 2026Q3, underscoring the company's reliance on non-recurring project-based milestones rather than a predictable, scalable commercial revenue stream from its core cell therapy platform.

The lack of consistent top-line growth suggests that the company is still in a transitional phase, attempting to pivot from pure R&D to a service-oriented model. Investors should monitor whether future revenue reflects genuine commercial traction in CDMO services or merely the timing of sporadic grant-funded research activities.

Structural Margin Instability Remains Prevalent

According to historical income statements, Pluri's gross margins have fluctuated wildly from 100% in early 2024 to negative territory in 2026Q2, reflecting the inherent unpredictability of a business model that lacks a stable, high-volume product manufacturing base to offset fixed operational costs.

The extreme volatility in gross margins suggests that the company's cost structure is not yet optimized for commercial production. This inconsistency makes it difficult to forecast future profitability, as the current margin profile appears highly sensitive to the specific nature of each quarter's revenue recognition.

Operating Leverage Remains Severely Constrained

Based on reported financial figures, Pluri continues to exhibit a massive structural imbalance, with operating expenses consistently dwarfing gross profit, resulting in an operating margin of -39.2% in 2026Q3 and highlighting the company's inability to achieve meaningful operating leverage at current scale.

The persistent gap between R&D spending and revenue generation indicates that the company remains in a high-burn phase with no clear path to operational self-sufficiency. Without a significant increase in revenue volume, the current overhead structure appears unsustainable and likely to necessitate further capital raises.

Earnings Quality Diluted by SBC

As reported in recent filings, Pluri's net income is consistently negative, with significant stock-based compensation expenses—reaching $1.4M in 2026Q1—further complicating the assessment of true operational performance and contributing to the ongoing dilution of existing shareholders in the absence of positive cash flow.

The reliance on stock-based compensation as a primary tool for managing cash burn warrants close scrutiny, as it masks the true cost of talent acquisition and retention. Investors should be wary of the impact these non-cash charges have on the overall quality of earnings and the long-term dilution profile.

Sustainability of Current Business Model

Financial statements reveal a concerning trend where the company's cash runway is rapidly depleting, with quarterly operating losses consistently exceeding $5M, suggesting that the current business model may be fundamentally unviable without a major, non-dilutive capital injection or a rapid commercial breakthrough.

Short-sellers would likely focus on the persistent cash burn and the lack of a clear, recurring revenue path as evidence of a failing business model. The reliance on government grants and the uncertainty surrounding clinical trial outcomes present significant risks that could lead to further shareholder value erosion.

PLUR — Frequently Asked Questions

Quick answers to the most common questions about buying PLUR stock.

What was Pluri Inc.'s (PLUR) revenue in 2026?

For fiscal year 2026, Pluri Inc. (PLUR) reported total revenue of $1.0M.

Is Pluri Inc. (PLUR) profitable?

Pluri Inc. (PLUR) reported a net loss of $23.8M for the fiscal year ending 2026.

What is Pluri Inc.'s operating profit margin?

Pluri Inc. (PLUR) reported an operating income of $-24.9M, resulting in an operating profit margin of -2454.5%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Pluri Inc.'s gross profit and gross margin?

Pluri Inc. (PLUR) generated $0.5M in gross profit for the year, representing a gross profit margin of 44.6%. This demonstrates the company's core pricing power and production efficiency.